Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Intel Shares Experience Dramatic Swings Following Multi-Billion Dollar Partnership

Dieter Jaworski by Dieter Jaworski
September 20, 2025
in Analysis, Mergers & Acquisitions, Semiconductors, TecDAX, Trading & Momentum
0
Intel Stock
0
SHARES
118
VIEWS
Share on FacebookShare on Twitter

Investors in Intel have been on a turbulent ride this week, witnessing one of the most significant single-day rallies in decades followed by a sharp pullback. The extreme volatility stems from a landmark announcement and subsequent market reactions that have left Wall Street deeply divided on the chipmaker’s prospects.

A Landmark Deal and Subsequent Sell-Off

The semiconductor giant’s shares recorded their most substantial single-day gain in years, soaring over 20%, following the unexpected news of a strategic partnership. The catalyst was a $5 billion investment commitment from NVIDIA, a longstanding rival. The two industry leaders announced plans to collaborate on developing products for data centers and personal computers, a move that caught many market observers by surprise.

This euphoria proved short-lived. By Friday, a pronounced correction was underway as the stock gave back a significant portion of its gains. Market strategists attributed the sell-off to profit-taking following the spectacular advance, a common occurrence after such dramatic upward moves.

Analytical Community Shows Sharp Divisions

The financial community has responded to these developments with markedly contrasting views. While at least four major investment banks raised their price targets for Intel following the NVIDIA announcement, Citigroup bucked the trend. The firm downgraded its rating on Intel from “Neutral” to “Sell,” directly countering the prevailing optimism and creating headwinds for the continuing rally.

Should investors sell immediately? Or is it worth buying Intel?

Key questions dividing market participants include:
* Whether the stock has become overvalued following its explosive price movement
* The long-term viability of Intel’s foundry operations against established competitors
* The strategic importance of the NVIDIA collaboration for artificial intelligence infrastructure development

Foundry Business Remains Central Concern

Much of the skepticism centers on Intel’s foundry segment, which manufactures chips for other companies. Analysts at Citigroup expressed particular concern, stating they see “minimal chances of success” against formidable competition. They contend that the current share price already reflects expectations for a successful turnaround in this historically challenging and loss-making division.

Although the NVIDIA partnership could provide a crucial lifeline, significant doubts about implementation capabilities and ultimate competitiveness continue to weigh on investor sentiment. The coming quarters will prove decisive in determining whether the chipmaker can deliver on these heightened expectations.

Ad

Intel Stock: Buy or Sell?! New Intel Analysis from February 8 delivers the answer:

The latest Intel figures speak for themselves: Urgent action needed for Intel investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 8.

Intel: Buy or sell? Read more here...

Tags: Intel
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Rock Tech Lithium Stock
Analysis

Rock Tech Lithium: Investors Await the Final Go-Ahead

February 8, 2026
Quanterix Stock
Analysis

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

February 8, 2026
Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Next Post
Opendoor Stock

Leadership Shakeup and Strategic Pivot Drive Opendoor Stock Volatility

Amazon Stock

Amazon's Bureaucracy Revolution: Jassy's Efficiency Drive Gains Momentum

Plug Power Stock

Is Plug Power Stock Primed for a Hydrogen Resurgence?

Recommended

UBS Stock

UBS Share Buyback Fails to Impress Amid Regulatory Fears

3 months ago
IBM Stock

IBM’s UFC Partnership Showcases AI Capabilities in Live Sports

3 months ago
ImmunityBio Stock

ImmunityBio Shares Gain Momentum on Strong Revenue and Regulatory Progress

6 days ago
BioNTech Stock

BioNTech’s Billion-Euro Forecast Shift Stuns Market

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

Repay Holdings: Annual Report to Test Strategic Refinancing Success

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Trending

Rock Tech Lithium Stock
Analysis

Rock Tech Lithium: Investors Await the Final Go-Ahead

by Jackson Burston
February 8, 2026
0

Investors in Rock Tech Lithium are in a holding pattern, with all eyes fixed on a pending...

Puma Biotechnology Stock

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

February 8, 2026
Quanterix Stock

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

February 8, 2026
Design Therapeutics Stock

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Rock Tech Lithium: Investors Await the Final Go-Ahead
  • Puma Biotechnology Sets Date for Full-Year Financial Disclosure
  • Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com